- Home
- DAWN vs JKS Comparison
DAWN vs JKS Comparison
Compare DAWN & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- JKS
- Stock Information
- Founded
- DAWN 2018
- JKS 2006
- Country
- DAWN United States
- JKS China
- Employees
- DAWN N/A
- JKS N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- JKS Semiconductors
- Sector
- DAWN Health Care
- JKS Technology
- Exchange
- DAWN Nasdaq
- JKS Nasdaq
- Market Cap
- DAWN 1.3B
- JKS 1.4B
- IPO Year
- DAWN 2021
- JKS 2010
- Fundamental
- Price
- DAWN $12.15
- JKS $20.88
- Analyst Decision
- DAWN Strong Buy
- JKS Hold
- Analyst Count
- DAWN 7
- JKS 7
- Target Price
- DAWN $36.33
- JKS $28.42
- AVG Volume (30 Days)
- DAWN 1.1M
- JKS 844.8K
- Earning Date
- DAWN 02-24-2025
- JKS 03-19-2025
- Dividend Yield
- DAWN N/A
- JKS 14.18%
- EPS Growth
- DAWN N/A
- JKS N/A
- EPS
- DAWN N/A
- JKS 0.89
- Revenue
- DAWN $101,953,000.00
- JKS $14,888,551,409.00
- Revenue This Year
- DAWN N/A
- JKS N/A
- Revenue Next Year
- DAWN $34.82
- JKS $5.44
- P/E Ratio
- DAWN N/A
- JKS $22.25
- Revenue Growth
- DAWN N/A
- JKS N/A
- 52 Week Low
- DAWN $11.13
- JKS $16.70
- 52 Week High
- DAWN $18.07
- JKS $37.36
- Technical
- Relative Strength Index (RSI)
- DAWN 44.59
- JKS 34.05
- Support Level
- DAWN $11.93
- JKS $19.75
- Resistance Level
- DAWN $13.53
- JKS $21.43
- Average True Range (ATR)
- DAWN 0.56
- JKS 1.21
- MACD
- DAWN 0.03
- JKS -0.18
- Stochastic Oscillator
- DAWN 35.21
- JKS 7.74
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific (except China, which includes Hong Kong and Taiwan), and the Rest of the world.